Cellmark Theranostics LLC is categorized under Medical Labs in Parsippany, NJ and active since 2011.
Cellmark Theranostics LLC was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Ronald Stevenson at the company’s single location by writing to 300 Interpace Parkway # 410, Parsippany, New Jersey NJ 07054 or by phoning (973) 316-9900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cellmark Theranostics LLC |
| Contact Person: | Ronald Stevenson |
| Address: | 300 Interpace Parkway # 410, Parsippany, New Jersey 07054 |
| Phone Number: | (973) 316-9900 |
| Website Address: | thinkblueslate.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Cellmark Theranostics LLC was started in 2011 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Ronald Stevenson for inquiries that concern Cellmark Theranostics LLC by calling the company number (973) 316-9900, as your correspondence is most welcome. Additionally, the physical location of the single location of Cellmark Theranostics LLC can be found at the coordinates 40.868435,-74.447805 as well as the street address 300 Interpace Parkway # 410 in Parsippany, New Jersey 07054.
For its online presence, you may visit Cellmark Theranostics LLC’s website at thinkblueslate.com and engage with its social media outlets through on Twitter and on Facebook.